# Cabazitaxel and Radiation For Patients With Prostate Cancer

> **NCT01650285** · PHASE2 · TERMINATED · sponsor: **Brown University** · enrollment: 5 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Cabazitaxel

## Key facts

- **NCT ID:** NCT01650285
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** slow recruitment and lost funding
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650285, "Cabazitaxel and Radiation For Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01650285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*